SEARCH

SEARCH BY CITATION

References

  • 1
    Old LJ,Chen YT. New paths in human cancer serology. J Exp Med 1998; 187: 11637.
  • 2
    Scanlan MJ,Gure AO,Jungbluth AA,Old LJ,Chen YT. Cancer/testis antigens: an expanding family of target for cancer immunotherapy. Immunol Rev 2002; 188: 2232.
  • 3
    Jungbluth AA,Chen YT,Stockert E,Busam KJ,Kolb D,Iversen K,Coplan K,Williamson B,Altorki N,Old LJ. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001; 92: 85660.
  • 4
    Scanlan MJ,Simpson AJG,Old LJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immun 2004; 4: 1.
  • 5
    Van der Bruggen P,Traversari C,Chomez P,Lurquin C,De Plaen E,Van den Eynde B,Knuth A,Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 16437.
  • 6
    Boël P,Wildmann C,Sensi ML,Brasseur R,Renauld JC,Coulie P,Boon T,van der Bruggen P. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995; 2: 16775.
  • 7
    Van den Eynde B,Peeters O,De Backer O,Gaugler B,Lucas S,Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on human melanoma. J Exp Med 1995; 182: 68998.
  • 8
    Lethé B,Lucas S,Michaux L,De Smet C,Godelaine D,Serrano A,De Plaen E,Boon T. LAGE-1, a new gene with tumor specificity. Int J Cancer 1998; 76: 9038.
  • 9
    Sasaki M,Nakahira K,Kawano Y,Katakura H,Yoshimine T,Shimizu K,Kim SU,Ikenaka K. MAGE-E1, a new member of the melanoma-associated antigen gene family and its expression in human glioma. Cancer Res 2001; 61: 480914.
  • 10
    Martelange V,De Smet C,De Plaen E,Lurquin C,Boon T. Identification on a human sarcoma of two new genes with tumor-specific expression. Cancer Res 2000; 60: 384855.
  • 11
    De Wit NJ,Weidle UH,Rutter DJ,Muuen GN. Expression profiling of MMA-1A and splice variant MMA-1B: new cancer/testis antigens identified in human melanoma. Int J Cancer 2002; 98: 54753.
  • 12
    Scanlan MJ,Altorki NK,Gure AO,Williamson B,Jungbluth A,Chen YT,Old LJ. Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis- specific gene (BRDT) as a new CT gene. CT9. Cancer Lett 2000; 150: 15564.
  • 13
    Ono T,Kurashige T,Harada N,Noguchi Y,Saika T,Niikawa N,Aoe M,Nakamura S,Higashi T,Hiraki A,Wada H,Kumon H, et al. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc Natl Acad Sci USA 2001; 98: 32827.
  • 14
    Scanlan MJ,Gordon CM,Williamson B,Lee SY,Chen YT,Stockert E,Jungbluth A,Ritter G,Jäger D,Jäger E,Knuth A,Old LJ. Identification of cancer/testis genes by database mining and mRNA expression analysis. Int J Cancer 2002; 98: 48592.
  • 15
    Koslowski M,Türeci O,Bell C,Krause P,Lehr HA,Brunner J,Seitz G,Nestle FO,Huber C,Sahin U. Multiple splice variants of lactate dehydrogenase C selectively expression in human cancer. Cancer Res 2002; 62: 67505.
  • 16
    Dong XY,Su YR,Qian XP,Yang XA,Pang XW,Wu HY,Chen WF. Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patoents. Br J Cancer 2003; 89: 2917.
  • 17
    Gure AO,Türeci O,Sahin U,Tsang S,Scanlan MJ,Jäger E,Knuth A,Pfreundschuh M,Old LJ,Chen YT. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer 1997; 72: 96571.
  • 18
    Tureci O,Sahin U,Zwick C,Koslowski M,Seitz G,Pfreundschuh M. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci USA 1998; 95: 52116.
  • 19
    Chen YT,Scanlan MJ,Sahin U,Türeci O,Gure AO,Tsang S,Williamson B,Stockert E,Pfreundschuh M,Old LJ. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997; 94: 19148.
  • 20
    Ali Eldib AM,Ono T,Shimono M,Kaneko M,Nakagawa K,Tanaka R,Noguchi Y,Nakayama E. Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: identification of XAGE-1b as a dominant antigen and its immunologenicity in lung adenocarcinoma. Int J Cancer 2004; 108: 55863.
  • 21
    Yuasa K,Omori K,Yanaka N. Binding and phosphorylation of a novel male germ cell-specific cGMP-dependent protein kinase-anchoring protein by cGMP-dependent protein kinase Iα. J Biol Chem 2000; 275: 4897905.
  • 22
    Simpson AJ,Caballero OL,Jungbluth A,Chen YT,Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005; 5: 61525.
  • 23
    Bavner A,Matthews J,Sanyal S,Gustafsson JA,Treuter E. EID3 is a novel EID family member and an inhibitor of CBP-dependent co-activation. Nucleic Acids Res 2005; 33: 35619.
  • 24
    Feliciello A,Gottesman ME,Avvedimento V. The biological functions of A-kinase anchor proteins. J Mol Biol 2001; 308: 99114.
  • 25
    Hasegawa K,Ono T,Matsushita H,Shimono M,Noguchi Y,Mizutani Y,Kodama J,Kudo T,Nakayama E. A-kinase anchoring protein 3 messenger RNA expression in ovarian cancer and its implication on prognosis. Int J Cancer 2004; 108: 8690.
  • 26
    Stockert E,Jäger E,Chen YT,Scanlan MJ,Gout I,Karbach J,Arand M,Knuth A,Old LJ. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 1998; 187: 134954.
  • 27
    Jäger E,Nagata Y,Gnjatic S,Wada H,Stockert E,Karbach J,Dunbar PR,Lee SY,Jungbluth A,Jäger D,Arand M,Ritter G, et al. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci USA 2000; 97: 47605.
  • 28
    Kurashige T,Noguchi Y,Saika T,Ono T,Nagata Y,Jungbluth A,Ritter G,Chen YT,Stockert E,Tsushima T,Kumon H,Old LJ, et al. NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Cancer Res 2001; 61: 46714.
  • 29
    Fujita S,Wada H,Jungbluth AA,Sato S,Nakata T,Noguchi Y,Doki Y,Yasui M,Sugita Y,Yasuda T,Yano M,Ono T, et al. NY-ESO-1 expression and immunogenicity in esophageal cancer. Clin Cancer Res 2004; 10: 65518.
  • 30
    Gnjatic S,Nishikawa H,Jungbluth AA,Güre AO,Ritter G,Jäger E,Knuth A,Chen YT,Old LJ. NY-ESO-1: review of an immunogenic tumor antigen. Adv Cancer Res 2006; 95: 130.
  • 31
    Uenaka A,Wada H,Isobe M,Saika T,Tsuji K,Sato E,Sato S,Noguchi Y,Kawabata R,Yasuda T,Doki Y,Kumon H, et al. T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. Cancer Immun 2007; 7: 9.
  • 32
    Nakagawa K,Noguchi Y,Uenaka A,Sato S,Okumura H,Tanaka M,Shimono M,Ali Eldib AM,Ono T,Ohara N,Yoshino T,Yamashita K, et al. XAGE-1 expression in non-small cell lung cancer and antibody response in patients. Clin Cancer Res 2005; 11: 5496503.
  • 33
    Scanlan MJ,Gordon CM,Williamson B,Lee SY,Chen YT,Stockert E,Jungbluth A,Ritter G,Jäger D,Jäger E,Knuth A,Old LJ. Identification of cancer/testis genes by database mining and mRNA expression analysis. Int J Cancer 2002; 98: 48592.
  • 34
    Slingluff CL,Jr,Petroni GR,Chianese-Bullock KA,Smolkin ME,Hibbitts S,Murphy C,Johansen N,Grosh WW,Yamshchikov GV,Neese PY,Patterson JW,Fink R, et al. Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting. Clin Cancer Res 2007; 13: 638695.
  • 35
    Matsushita H,Uenaka A,Ono T,Hasegawa K,Sato S,Koizumi F,Nakagawa K,Toda M,Shingo T,Ichikawa T,Noguchi Y,Tamiya T, et al. Identification of glioma-specific RFX4-E and -F isoforms and humoral immune response in patients. Cancer Sci 2005; 96: 8019.
  • 36
    Tanaka R,Ono T,Sato S,Nakada T,Koizumi F,Hasegawa K,Nakagawa K,Okumura H,Yamashita T,Ohtsuka M,Asagoe K,Yamasaki O, et al. Over-expression of the testis-specific gene TSGA10 in cancers and its immunogenicity. Microbiol Immunol 2004; 48: 33945.